Navigation Links
Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research

ymptoms. Santaris Pharma holds the world wide patent rights to the exploitation of LNA in pharmaceuticals and presently has three drugs in preclinical or clinical development. The lead drug candidate, SPC2996, is currently undergoing international, multicenter, phase I/II clinical studies in Chronic Lymphocytic Leukaemia.

For further company information see www.santaris.com <http://www.santaris.com/>

Forward Looking Statements

There are forward-looking statements contained herein, which can be identified by the use of forward-looking terminology such as the words "believes," "expects," "may," "will," "should", "potential," "anticipates," "plans" or "intends" and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from the future results, events or developments indicated in such forward-looking statements. Such factors include, but are not limited to the timing, success and cost of clinical studies; the ability to obtain regulatory approval of products, market acceptance of and future demand for Santaris products and the impact of competitive products and pricing. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. No assurance can be given that the future results covered by the forward-looking statements will be achieved. All information in this press release is as of the date of this press release and Santaris does not intend to update this information.

Best regards

Annabel Entress Account Manager --------------------------------------------- Direct line: +44 (0)20 7268 3234

Main tel: +44 (0)20 7268 3002 Fax: +44 (0)20 7268 3102

Please note our new contact details:

85 Totte
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:8/29/2014)... Corporation , a neurodiagnostics medical device company based in ... Forcht Dagi , MD, DmedSc, MPH, MBA, FACS, FRCSEd  was ... " Teo Forcht Dagi is an experienced leader with ... said Remis Bistras , President and CEO of Vittamed. ... entrepreneurial expertise to our Board." Dr. Dagi is ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely eradicated ... generation ago are returning. Measles was declared eliminated in ... 2014 as of August 15—the highest incidence in 20 ... health department declared whooping cough a problem of ... getting sick and dying from these preventable diseases—in part ...
(Date:8/29/2014)... -- ChemImage will present a workshop focused on hyperspectral ... Science Society,s 22 nd International Symposium on ... .  Forensic Scientists will be in attendance ... can bring to examination procedures. ... Development at ChemImage, will host a workshop during ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... The Department of Justice, on behalf of the U.S. Food ... permanent injunction against generic drug manufacturer Ranbaxy in the ... filed against Ranbaxy Laboratories, Ltd., an Indian corporation; its ... Dale Adkisson, senior vice president, head of global quality, ...
... Fine Chemicals LLC (AFC), a wholly owned subsidiary of ... today that is has been granted Registration as a ... Agency (DEA). AFC has been involved in ... under a Researcher,s License from the DEA.  Recent facilities ...
Cached Medicine Technology:Department of Justice files consent decree of permanent injunction against Ranbaxy 2Department of Justice files consent decree of permanent injunction against Ranbaxy 3Department of Justice files consent decree of permanent injunction against Ranbaxy 4AMPAC Fine Chemicals Expands Into Controlled Substance Manufacturing 2AMPAC Fine Chemicals Expands Into Controlled Substance Manufacturing 3AMPAC Fine Chemicals Expands Into Controlled Substance Manufacturing 4
(Date:8/30/2014)... 2014 "I had a handicapped friend who ... said an inventor from Wetumpka, Ala. "In order to help ... the shore, I came up with a way for her ... a prototype for the patent-pending Deezers to allow crutches to ... to use crutches, walkers, or canes at the beach. The ...
(Date:8/30/2014)... Seattle, WA (PRWEB) August 30, 2014 One ... of this era is the gluten-free diet. Originally meant for ... has become a catchall for people who are looking to ... gluten. However, not only is this kind of information erroneous, ... of health problems because of a drastic change in ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 August 28th, ... shoulder pain in our society and the toll that ... costs, it’s vital that continuing education for physical therapists ... to help physical therapists help others, Hands-On Seminars is ... , Three learning styles are available to ...
(Date:8/30/2014)... When a prominent bank reveals a successful cyber ... August 27th, when news began surfacing about the FBI ... and at least one other bank. But when news ... on seven prominent banks , everyone starts thinking about their ... buzz quickly goes viral. Bloomberg followed up on Friday ...
(Date:8/30/2014)... 2014 As 500 Zoloft lawsuits pending ligation ... to pregnant mothers, Wright & Schulte LLC recently learned of ... The remand in the Zoloft lawsuits was granted ... and are involved in one SSRI lawsuit filed jointly ... Zoloft birth defect lawsuit sent back to the Missouri state ...
Breaking Medicine News(10 mins):Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 3Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 4Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 5Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5
... to bad treatment decisions, study shows , , FRIDAY, ... receive about the risk of their breast cancer ... whether to get chemotherapy more difficult, a new ... patients a bar chart, based on a standard ...
... America,s Largest Chemical Industry Trade Fair Offers New Chemists and ... Industry , , PRINCETON, N.J., ... invite young chemists to attend the upcoming InformexUSA exhibition in ... for chemists and chemical engineers 25 and under to learn ...
... Standing in the gymnasium of the,Glendale Event Center early Sunday ... squeaks of hurried athletic shoes echoed throughout the,room. , ... would have thought they were,overhearing a raucous game of pickup ... teammates to pass them the ball: "I,m open! Over,here!" , ...
... Food Allergies Send 50,000 Americans to the Emergency Room Annually , ... A new study from the Mayo Clinic published in the December ... (JACI) indicates a higher incidence of anaphylactic reactions than previously reported. ... entitled "The etiology and incidence of anaphylaxis in Rochester, Minnesota," Wyatt ...
... drug discovery including solutions to tackle obesity, the ... surrounding drugs used in sport and the Olympics ... week. , The British Pharmacological Society (BPS), Europe,s leading ... in the seaside resort, attracting experts from across the ...
... Relations Worldwide (Ogilvy PR), an integrated global communications firm, ... comprehensive communications support contract with the National Cancer Institute ... be performed by Ogilvy PR,s Washington, DC-based Social Marketing ... subsidiary, Feinstein Kean Healthcare (FKH). , ...
Cached Medicine News:Health News:Risk Info for Breast Cancer Patients Too Confusing 2Health News:Informex Invites Young Chemists to Attend InformexUSA 2Health News:Informex Invites Young Chemists to Attend InformexUSA 3Health News:The 2008 Youth Conference on the Game: A Weekend to Learn, Play and Honor 2Health News:The 2008 Youth Conference on the Game: A Weekend to Learn, Play and Honor 3Health News:The 2008 Youth Conference on the Game: A Weekend to Learn, Play and Honor 4Health News:The 2008 Youth Conference on the Game: A Weekend to Learn, Play and Honor 5Health News:The 2008 Youth Conference on the Game: A Weekend to Learn, Play and Honor 6Health News:Incidence of Anaphylaxis Higher Than Previously Reported 2Health News:Incidence of Anaphylaxis Higher Than Previously Reported 3Health News:Leading pharmacologists to meet in Brighton 2Health News:National Cancer Institute Selects Ogilvy Public Relations Worldwide for Comprehensive Multi-Year Communications Support 2
Straight shafts with 4 mm jaws. Serrated handle with dull finish. Jaws straight....
Double-ended. 10 mm sickle shaped blade. 27 mm blunt, curved double-edged blade....
25 mm blunt, double-edged blade. Flat handle....
Fixed smooth rod which slides on skin. Designated most popular model or size....
Medicine Products: